122 related articles for article (PubMed ID: 11782470)
1. Expression of the Gb3/CD77 synthase gene in megakaryoblastic leukemia cells: implication in the sensitivity to verotoxins.
Furukawa K; Yokoyama K; Sato T; Wiels J; Hirayama Y; Ohta M; Furukawa K
J Biol Chem; 2002 Mar; 277(13):11247-54. PubMed ID: 11782470
[TBL] [Abstract][Full Text] [Related]
2. Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins.
Okuda T; Tokuda N; Numata S; Ito M; Ohta M; Kawamura K; Wiels J; Urano T; Tajima O; Furukawa K; Furukawa K
J Biol Chem; 2006 Apr; 281(15):10230-5. PubMed ID: 16476743
[TBL] [Abstract][Full Text] [Related]
3. Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry.
Szymczak-Kulus K; Weidler S; Bereznicka A; Mikolajczyk K; Kaczmarek R; Bednarz B; Zhang T; Urbaniak A; Olczak M; Park EY; Majorczyk E; Kapczynska K; Lukasiewicz J; Wuhrer M; Unverzagt C; Czerwinski M
J Biol Chem; 2021; 296():100299. PubMed ID: 33460651
[TBL] [Abstract][Full Text] [Related]
4. Two distinct Gb3/CD77 signaling pathways leading to apoptosis are triggered by anti-Gb3/CD77 mAb and verotoxin-1.
Tétaud C; Falguières T; Carlier K; Lécluse Y; Garibal J; Coulaud D; Busson P; Steffensen R; Clausen H; Johannes L; Wiels J
J Biol Chem; 2003 Nov; 278(46):45200-8. PubMed ID: 12944404
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of the human Gb3/CD77 synthase gene promoter.
Okuda T; Nakayama K
Glycobiology; 2008 Dec; 18(12):1028-35. PubMed ID: 18757779
[TBL] [Abstract][Full Text] [Related]
6. The blood group P1 synthase gene is identical to the Gb3/CD77 synthase gene. A clue to the solution of the P1/P2/p puzzle.
Iwamura K; Furukawa K; Uchikawa M; Sojka BN; Kojima Y; Wiels J; Shiku H; Urano T; Furukawa K
J Biol Chem; 2003 Nov; 278(45):44429-38. PubMed ID: 12888565
[TBL] [Abstract][Full Text] [Related]
7. A single point mutation in the gene encoding Gb3/CD77 synthase causes a rare inherited polyagglutination syndrome.
Suchanowska A; Kaczmarek R; Duk M; Lukasiewicz J; Smolarek D; Majorczyk E; Jaskiewicz E; Laskowska A; Wasniowska K; Grodecka M; Lisowska E; Czerwinski M
J Biol Chem; 2012 Nov; 287(45):38220-30. PubMed ID: 22965229
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen.
Mangeney M; Lingwood CA; Taga S; Caillou B; Tursz T; Wiels J
Cancer Res; 1993 Nov; 53(21):5314-9. PubMed ID: 8221667
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an amino acid residue critical for the specificity and activity of human Gb3/CD77 synthase.
Kaczmarek R; Mikolajewicz K; Szymczak K; Duk M; Majorczyk E; Krop-Watorek A; Buczkowska A; Czerwinski M
Glycoconj J; 2016 Dec; 33(6):963-973. PubMed ID: 27538840
[TBL] [Abstract][Full Text] [Related]
10. Two Paralogous Gb3/CD77 Synthases in Birds Show Different Preferences for Their Glycoprotein and Glycosphingolipid Substrates.
Bereznicka A; Mikolajczyk K; Szymczak-Kulus K; Kapczynska K; Majorczyk E; Modlinska A; Piasecki T; Kaczmarek R; Czerwinski M
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575935
[TBL] [Abstract][Full Text] [Related]
11. One of the two N-glycans on the human Gb3/CD77 synthase is essential for its activity and allosterically regulates its function.
Mikolajczyk K; Sikora M; Hanus C; Kaczmarek R; Czerwinski M
Biochem Biophys Res Commun; 2022 Aug; 617(Pt 1):36-41. PubMed ID: 35671609
[TBL] [Abstract][Full Text] [Related]
12. Human Gb3/CD77 synthase reveals specificity toward two or four different acceptors depending on amino acid at position 211, creating P(k), P1 and NOR blood group antigens.
Kaczmarek R; Duk M; Szymczak K; Korchagina E; Tyborowska J; Mikolajczyk K; Bovin N; Szewczyk B; Jaskiewicz E; Czerwinski M
Biochem Biophys Res Commun; 2016 Jan; 470(1):168-174. PubMed ID: 26773500
[TBL] [Abstract][Full Text] [Related]
13. [Megakaryocytic leukemia cell lines and megakaryocytic leukemia].
Ryo R; Yoshida A; Yamaguchi N
Rinsho Byori; 1990 May; 38(5):514-23. PubMed ID: 2381077
[TBL] [Abstract][Full Text] [Related]
14. Missing the sweet spot: one of the two N-glycans on human Gb3/CD77 synthase is expendable.
Mikolajczyk K; Bereznicka A; Szymczak-Kulus K; Haczkiewicz-Lesniak K; Szulc B; Olczak M; Rossowska J; Majorczyk E; Kapczynska K; Bovin N; Lisowska M; Kaczmarek R; Miazek A; Czerwinski M
Glycobiology; 2021 Sep; 31(9):1145-1162. PubMed ID: 33978735
[TBL] [Abstract][Full Text] [Related]
15. Acquired Resistance to Shiga Toxin-Induced Apoptosis by Loss of CD77 Expression in Human Myelogenous Leukemia Cell Line, THP-1.
Hattori T; Watanabe-Takahashi M; Nishikawa K; Naito M
Biol Pharm Bull; 2018; 41(9):1475-1479. PubMed ID: 30175782
[TBL] [Abstract][Full Text] [Related]
16. Differential role of FL-BID and t-BID during verotoxin-1-induced apoptosis in Burkitt's lymphoma cells.
Debernardi J; Hollville E; Lipinski M; Wiels J; Robert A
Oncogene; 2018 May; 37(18):2410-2421. PubMed ID: 29440708
[TBL] [Abstract][Full Text] [Related]
17. Shiga Toxins as Antitumor Tools.
Robert A; Wiels J
Toxins (Basel); 2021 Sep; 13(10):. PubMed ID: 34678982
[TBL] [Abstract][Full Text] [Related]
18. Gastric Adenocarcinomas Express the Glycosphingolipid Gb3/CD77: Targeting of Gastric Cancer Cells with Shiga Toxin B-Subunit.
Geyer PE; Maak M; Nitsche U; Perl M; Novotny A; Slotta-Huspenina J; Dransart E; Holtorf A; Johannes L; Janssen KP
Mol Cancer Ther; 2016 May; 15(5):1008-17. PubMed ID: 26826119
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning of globotriaosylceramide/CD77 synthase, a glycosyltransferase that initiates the synthesis of globo series glycosphingolipids.
Kojima Y; Fukumoto S; Furukawa K; Okajima T; Wiels J; Yokoyama K; Suzuki Y; Urano T; Ohta M; Furukawa K
J Biol Chem; 2000 May; 275(20):15152-6. PubMed ID: 10748143
[TBL] [Abstract][Full Text] [Related]
20. Globotriaosyl ceramide (CD77/Gb3) in the glycolipid-enriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating lyn kinase activity in human B cells.
Mori T; Kiyokawa N; Katagiri YU; Taguchi T; Suzuki T; Sekino T; Sato N; Ohmi K; Nakajima H; Takeda T; Fujimoto J
Exp Hematol; 2000 Nov; 28(11):1260-8. PubMed ID: 11063874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
